Paul Curley

1.5k total citations
37 papers, 677 citations indexed

About

Paul Curley is a scholar working on Infectious Diseases, Pharmaceutical Science and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Paul Curley has authored 37 papers receiving a total of 677 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Infectious Diseases, 9 papers in Pharmaceutical Science and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Paul Curley's work include HIV/AIDS drug development and treatment (12 papers), Advanced Drug Delivery Systems (8 papers) and HIV Research and Treatment (7 papers). Paul Curley is often cited by papers focused on HIV/AIDS drug development and treatment (12 papers), Advanced Drug Delivery Systems (8 papers) and HIV Research and Treatment (7 papers). Paul Curley collaborates with scholars based in United Kingdom, United States and Switzerland. Paul Curley's co-authors include Andrew Owen, Marco Siccardi, Steve P. Rannard, Darren Moss, Michael McMahon, Neill J. Liptrott, Rosamonde E. Banks, J T Whicher, F. Lancaster and Justin Chiong and has published in prestigious journals such as Nature Communications, Gastroenterology and The Journal of Infectious Diseases.

In The Last Decade

Paul Curley

33 papers receiving 650 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Paul Curley United Kingdom 17 234 144 137 127 110 37 677
Erik M. van Maarseveen Netherlands 20 171 0.7× 100 0.7× 176 1.3× 26 0.2× 35 0.3× 52 1.2k
Peter Hodsman United States 11 92 0.4× 33 0.2× 48 0.4× 14 0.1× 91 0.8× 18 677
David F. Evans United Kingdom 17 235 1.0× 77 0.5× 76 0.6× 273 2.1× 62 0.6× 22 943
Miriam Hurst New Zealand 15 51 0.2× 39 0.3× 126 0.9× 19 0.1× 112 1.0× 21 694
T Velpandian India 15 78 0.3× 64 0.4× 82 0.6× 59 0.5× 50 0.5× 31 628
K. Ojala Finland 15 82 0.4× 98 0.7× 40 0.3× 210 1.7× 75 0.7× 29 545
Laura Mihaela Trandafir Romania 15 153 0.7× 31 0.2× 82 0.6× 22 0.2× 88 0.8× 102 790
Jean-Charles Reynier France 11 116 0.5× 13 0.1× 144 1.1× 103 0.8× 43 0.4× 29 691
Sunil K. Jain United States 17 168 0.7× 28 0.2× 52 0.4× 25 0.2× 293 2.7× 48 762

Countries citing papers authored by Paul Curley

Since Specialization
Citations

This map shows the geographic impact of Paul Curley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Curley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Curley more than expected).

Fields of papers citing papers by Paul Curley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Curley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Curley. The network helps show where Paul Curley may publish in the future.

Co-authorship network of co-authors of Paul Curley

This figure shows the co-authorship network connecting the top 25 collaborators of Paul Curley. A scholar is included among the top collaborators of Paul Curley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul Curley. Paul Curley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dwyer, Andrew, Tom O. McDonald, Paul Curley, et al.. (2025). Development of solid drug nanoparticle dispersions for pulmonary delivery of niclosamide and nitazoxanide via vibrating mesh nebulisation. Research Explorer (The University of Manchester). 2(3). 517–526. 1 indexed citations
2.
3.
4.
Gallardo‐Toledo, Eduardo, Megan Neary, Joanne Sharp, et al.. (2023). Chemoprophylactic Assessment of Combined Intranasal SARS-CoV-2 Polymerase and Exonuclease Inhibition in Syrian Golden Hamsters. Viruses. 15(11). 2161–2161.
5.
Curley, Paul, Neill J. Liptrott, Edward Makarov, et al.. (2023). Preclinical Evaluation of Long-Acting Emtricitabine Semi-Solid Prodrug Nanoparticle Formulations. Pharmaceutics. 15(7). 1835–1835. 3 indexed citations
6.
Neary, Megan, Usman Arshad, Lee Tatham, et al.. (2023). Quantitation of tizoxanide in multiple matrices to support cell culture, animal and human research. Journal of Chromatography B. 1228. 123823–123823. 4 indexed citations
7.
Arshad, Usman, Henry Pertinez, Helen Box, et al.. (2021). Scalable nanoprecipitation of niclosamide and in vivo demonstration of long-acting delivery after intramuscular injection. Nanoscale. 13(13). 6410–6416. 14 indexed citations
8.
Curley, Paul, David J. Meyers, Charles Flexner, et al.. (2019). Semi-solid prodrug nanoparticles for long-acting delivery of water-soluble antiretroviral drugs within combination HIV therapies. Nature Communications. 10(1). 1413–1413. 35 indexed citations
9.
Rajoli, Rajith K. R., Paul Curley, Justin Chiong, et al.. (2018). Predicting Drug–Drug Interactions Between Rifampicin and Long-Acting Cabotegravir and Rilpivirine Using Physiologically Based Pharmacokinetic Modeling. The Journal of Infectious Diseases. 219(11). 1735–1742. 36 indexed citations
10.
Moss, Darren, et al.. (2017). The biological challenges and pharmacological opportunities of orally administered nanomedicine delivery. Expert Review of Gastroenterology & Hepatology. 12(3). 223–236. 40 indexed citations
11.
Scott, Philip, et al.. (2016). Measuring the operational impact of digitized hospital records: a mixed methods study. BMC Medical Informatics and Decision Making. 16(1). 143–143. 8 indexed citations
12.
Curley, Paul, Rajith K. R. Rajoli, Darren Moss, et al.. (2016). Efavirenz Is Predicted To Accumulate in Brain Tissue: an In Silico , In Vitro , and In Vivo Investigation. Antimicrobial Agents and Chemotherapy. 61(1). 27 indexed citations
13.
Alfirevic, Ana, Jill Durocher, David Dickens, et al.. (2015). Misoprostol-Induced Fever and Genetic Polymorphisms in Drug Transporters SLCO1B1 and ABCC4 in Women of Latin American and European Ancestry. Pharmacogenomics. 16(9). 919–928. 13 indexed citations
14.
Liptrott, Neill J., Paul Curley, Darren Moss, et al.. (2013). Interactions between tenofovir and nevirapine in CD4+ T cells and monocyte-derived macrophages restrict their intracellular accumulation. Journal of Antimicrobial Chemotherapy. 68(11). 2545–2549. 4 indexed citations
15.
Holzheimer, R. G., et al.. (2002). Circadian Rhythm of Cytokine Secretion Following Thermal Injury in Mice: Implications for Burn and Trauma Research. Shock. 17(6). 527–529. 20 indexed citations
16.
Curley, Paul, et al.. (1996). Decreased interleukin-2 production in murine acute pancreatitis: Potential for immunomodulation. Gastroenterology. 110(2). 583–588. 42 indexed citations
17.
Curley, Paul, et al.. (1996). Impact of the New Deal on vascular surgical training.. PubMed. 78(6 Suppl). 263–6. 9 indexed citations
18.
Holzheimer, R. G., R. G. Molloy, D. S. Ó’Ríordáin, et al.. (1995). Long-Term Immunotherapeutic Intervention with Pentoxifylline in a Mouse Model of Thermal Injury and Infection. PubMed. 38(5). 757–762. 7 indexed citations
19.
Martin, I. G., Paul Curley, & Michael McMahon. (1993). Minimally invasive treatment for common bile duct stones. British journal of surgery. 80(1). 103–106. 23 indexed citations
20.
Curley, Paul, et al.. (1989). Clinical Application of a New Enzyme-linked Assay for the Estimation of Brain-specific Creatine Kinase in Head Injured Patients. British Journal of Neurosurgery. 3(6). 655–658. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Erik M. van Maarseveen Breakdown of academic impact, for papers by Peter Hodsman Breakdown of academic impact, for papers by David F. Evans Breakdown of academic impact, for papers by Miriam Hurst Breakdown of academic impact, for papers by T Velpandian Breakdown of academic impact, for papers by K. Ojala Breakdown of academic impact, for papers by Laura Mihaela Trandafir Breakdown of academic impact, for papers by Jean-Charles Reynier Breakdown of academic impact, for papers by Sunil K. Jain
Rankless by CCL
2026